The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial

Christian Osadnik, Christine F McDonald, Belinda Miller, Catherine Hill, Ben Tarrant, Ranjana Steward, Caroline Chao, Nicole Stodden, Cristino C Oliveira, Nadia Gagliardi, Anne E Holland

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Positive expiratory pressure (PEP) is a technique used to enhance sputum clearance during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The impact of PEP therapy during acute exacerbations on clinically important outcomes is not clear. This study sought to determine the effect of PEP therapy on symptoms, quality of life and future exacerbations in patients with AECOPD.
Original languageEnglish
Pages (from-to)137 - 143
Number of pages7
JournalThorax
Volume69
Issue number2
DOIs
Publication statusPublished - 2014

Cite this

Osadnik, Christian ; McDonald, Christine F ; Miller, Belinda ; Hill, Catherine ; Tarrant, Ben ; Steward, Ranjana ; Chao, Caroline ; Stodden, Nicole ; Oliveira, Cristino C ; Gagliardi, Nadia ; Holland, Anne E. / The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial. In: Thorax. 2014 ; Vol. 69, No. 2. pp. 137 - 143.
@article{dad99e8d1a2d4aefa714a2e5947c5abb,
title = "The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial",
abstract = "Positive expiratory pressure (PEP) is a technique used to enhance sputum clearance during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The impact of PEP therapy during acute exacerbations on clinically important outcomes is not clear. This study sought to determine the effect of PEP therapy on symptoms, quality of life and future exacerbations in patients with AECOPD.",
author = "Christian Osadnik and McDonald, {Christine F} and Belinda Miller and Catherine Hill and Ben Tarrant and Ranjana Steward and Caroline Chao and Nicole Stodden and Oliveira, {Cristino C} and Nadia Gagliardi and Holland, {Anne E}",
year = "2014",
doi = "10.1136/thoraxjnl-2013-203425",
language = "English",
volume = "69",
pages = "137 -- 143",
journal = "Thorax",
issn = "0040-6376",
publisher = "BMJ Publishing Group",
number = "2",

}

The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial. / Osadnik, Christian; McDonald, Christine F; Miller, Belinda; Hill, Catherine; Tarrant, Ben; Steward, Ranjana; Chao, Caroline; Stodden, Nicole; Oliveira, Cristino C; Gagliardi, Nadia; Holland, Anne E.

In: Thorax, Vol. 69, No. 2, 2014, p. 137 - 143.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial

AU - Osadnik, Christian

AU - McDonald, Christine F

AU - Miller, Belinda

AU - Hill, Catherine

AU - Tarrant, Ben

AU - Steward, Ranjana

AU - Chao, Caroline

AU - Stodden, Nicole

AU - Oliveira, Cristino C

AU - Gagliardi, Nadia

AU - Holland, Anne E

PY - 2014

Y1 - 2014

N2 - Positive expiratory pressure (PEP) is a technique used to enhance sputum clearance during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The impact of PEP therapy during acute exacerbations on clinically important outcomes is not clear. This study sought to determine the effect of PEP therapy on symptoms, quality of life and future exacerbations in patients with AECOPD.

AB - Positive expiratory pressure (PEP) is a technique used to enhance sputum clearance during acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The impact of PEP therapy during acute exacerbations on clinically important outcomes is not clear. This study sought to determine the effect of PEP therapy on symptoms, quality of life and future exacerbations in patients with AECOPD.

UR - http://thorax.bmj.com/content/69/2/137.full.pdf+html

U2 - 10.1136/thoraxjnl-2013-203425

DO - 10.1136/thoraxjnl-2013-203425

M3 - Article

VL - 69

SP - 137

EP - 143

JO - Thorax

JF - Thorax

SN - 0040-6376

IS - 2

ER -